Propoxyphene safe enough but FDA recommends further studies
스크롤 이동 상태바
Propoxyphene safe enough but FDA recommends further studies
기자명
메디칼라이터팀
입력 2009.07.09 00:00
수정 2009.07.09 01:06
댓글 0
The Food and Drug Administration said that it will require stricter labeling of drugs containing propoxyphene, such as Darvon, which the European Union"s FDA equivalent , has phased out. The agency requires makers to add a boxed warning about the risk of fatal overdoses and further studies will be done on the effect of the drug on patients" heart function. The study will focus on how often elderly patients are prescribed propoxyphene compared with other pain relievers. The FDA received 91 reports of deaths linked to the medicine from 1969 to 2005. Most are related to overdoses and suicide attempts.